Home » Topics » Regulatory

Regulatory
RSS

FDA approves Coagadex for hereditary factor X deficiency

Oct. 21, 2015

FDA approves Praxbind as dabigatran reversal agent

Oct. 19, 2015

FDA approves Aristada for schizophrenia

Oct. 6, 2015

Maruho's Zebiax approved in Japan for bacterial skin infections

Sep. 30, 2015

Shionogi's Mulpleta approved in Japan for thrombocytopenia

Sep. 29, 2015

GlaxoSmithKline's Zagallo receives approval in Japan

Sep. 29, 2015

Japan first country to approve omarigliptin

Sep. 28, 2015

VivaGel BV approved in E.U. for bacterial vaginosis

Sep. 25, 2015

LFB's IVIg Iqymune approved in U.K. and Denmark

Sep. 22, 2015

FDA approves Vraylar for bipolar disorder and schizophrenia

Sep. 18, 2015

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....